- Emergence of Combined Kits for Dual Testing of Pregnancy and Ovulation.
- Emerging Nations to Offer New Growth Avenues.
- High Cost and Low Accuracy of Ivf Treatment.
- Rising Adoption of Basal Body Temperature-Based Ovulation Monitors.
Growth in the Fertility Test Market can be attributed to factors such as the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and increased awareness of fertility testing in both developed as well as developing countries.
On the other hand, the unproven accuracy of urine-based ovulation monitors in women suffering from PCOS and the lesser precision to confirm ovulation using ovulation predictions kits are the factors that are expected to restrain market growth to a certain extent in the coming years.
Key questions addressed in the report:
# What are the growth opportunities related to the adoption of fertility test products across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of ovulation prediction kits. Will this scenario continue in the next five years?
# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
# How will the increasing use of ovulation tracking mobile apps and fertility-tracking websites affect the growth of the market?
What the Market Looks Like?
The global fertility test market is expected to reach 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%.
Download PDF Brochure@ Fertility Test Market
The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US), among others.
Different Growth Strategies Adopted by Them:
Analysis of the market developments between 2015 and 2018 revealed that several growth strategies such as product launches, enhancements, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the fertility test market. Among these business strategies, product launches was the most widely adopted growth strategies by the players in the fertility test market.
# In 2017, Swiss Precision Diagnostics (Switzerland) launched its Clearblue Connected Ovulation Test System
# In 2017, NFI Consumer Healthcare (US) a division of Gregory Pharmaceutical Holdings (US) completed the acquisition of e.p.t over-the-counter pregnancy test kit brand from Prestige Brands Holdings.
# In 2017, Fairhaven Health (US), launched TempCue, a basal body temperature (BBT) thermometer.
# In 2016, Fertility Focus (UK) launched OvuSense App.
Request Sample Pages@ Fertility Test Market
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.